Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

JMCR Partners

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 23
Average round size
The average size of a deal this fund participated in
Portfolio companies 18
Rounds per year 2.30
Lead investments 12
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 1

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Clinical Trials
  • Medical

JMCR Partners is the famous VC, which was founded in 2013. The leading representative office of defined VC is situated in the Shanghai. The fund was located in Asia if to be more exact in China.

The typical startup value when the investment from JMCR Partners is 1-5 millions dollars. The top amount of exits for fund were in 2019. Opposing the other organizations, this JMCR Partners works on 4 percentage points more the average amount of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.

The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Tekeluo Biotech, Viva Biotech, Riparian Pharmaceuticals. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The typical case for the fund is to invest in rounds with 3-4 participants. The meaningful sponsors for the fund in investment in the same round are Yingqi Investment, Xiamen Changrong Investment Management, Viva BioInnovator.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of JMCR Partners:
Typical Co-investors
JMCR Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after JMCR Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Altivia Ventures Brazil, São Paulo, Sao Paulo
BTU Protocol Ecosystem Fund New York, New York, United States
Chemical Angel Network Houston, Texas, United States
Elevate Capital Oregon, Portland, United States
Focustar Capital -
GROWWS Czechia, Prague, Prague
Integrated Networks Ar Riyad, Riyadh, Saudi Arabia
Inter National Bank Mcallen, Texas, United States
Johnsonville Sausage United States, Watertown, Wisconsin
Newable England, London, United Kingdom
Next Orbit Ventures Fund-I India, Maharashtra, Mumbai
Rock River Capital Partners Madison, United States, Wisconsin
Sanden Gunma Prefecture, Isesaki, Japan
Shanghai Yijinghui Asset Management China, Shanghai
StartVenture California, San Francisco, United States
Suzhou Xiangtang Venture Capital China, Jiangsu, Suzhou
Uqalo -
Zhong Zao Weilai Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Clues Therapeutics Inc.

$1M20 Jul 2020 -

Anji Pharmaceuticals

$12M01 Jul 2020 Cambridge, Massachusetts, United States

Diagon, Inc.

$5M18 May 2020 Belgium, Liège, Belgium

Proviva Therapeutics, Inc

02 Jan 2020 -

VivaVision Biotech

$10M26 Sep 2019 Shanghai, China

Anji Pharmaceuticals

$14M28 Jun 2019 Cambridge, Massachusetts, United States

Riparian Pharmaceuticals

Health Care
$3M12 Oct 2018 Boston, Massachusetts, United States

Clues Therapeutics Inc.

$800K10 Sep 2018 -

SQZ Biotech

Life Science
$72M08 Aug 2018 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent JMCR Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: